Bio-Rad Laboratories Inc (BIO) Stock Analysis

Bio-Rad Laboratories Inc (BIO) is a publicly traded company in the HEALTHCARE sector. It trades at $305.90, carries a market capitalization of $8.17B, a price-to-earnings ratio of 50.74. This page summarizes the public market data, fundamentals, and frequently asked questions for BIO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

Market Sentiment

Bio-Rad Laboratories Inc currently has a Neutral sentiment score of 0.00.

About Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. is a premier global provider of innovative solutions in life sciences research and clinical diagnostics, delivering a comprehensive portfolio of products and technologies designed to advance scientific discovery and enhance patient care. The company specializes in tools for genomic research, proteomics, and diagnostic testing, catering to the diverse needs of researchers and healthcare professionals. With a steadfast commitment to quality and reliability, Bio-Rad's ...

GNG Research Analysis

GNG Research scores Bio-Rad Laboratories Inc (BIO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BIO.

Frequently Asked Questions

Does BIO pay dividends?

Bio-Rad Laboratories Inc (BIO) does not currently pay a regular dividend.

What is BIO's P/E ratio?

Bio-Rad Laboratories Inc has a price-to-earnings (P/E) ratio of 50.74.

What is BIO's market cap?

Bio-Rad Laboratories Inc (BIO) has a market capitalization of $8.17B with a current stock price of $305.90.